Compare HSAI & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HSAI | BHVN |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 2021 | 2022 |
| Metric | HSAI | BHVN |
|---|---|---|
| Price | $12.97 | $11.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 17 |
| Target Price | ★ $28.03 | $21.27 |
| AVG Volume (30 Days) | 1.0M | ★ 1.9M |
| Earning Date | 11-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $41.54 | N/A |
| Revenue Next Year | $41.46 | N/A |
| P/E Ratio | $61.18 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.36 | $7.48 |
| 52 Week High | $29.35 | $18.57 |
| Indicator | HSAI | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 31.13 | 40.23 |
| Support Level | N/A | $10.75 |
| Resistance Level | $19.29 | $12.03 |
| Average True Range (ATR) | 0.49 | 0.62 |
| MACD | -0.30 | -0.10 |
| Stochastic Oscillator | 14.11 | 24.62 |
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.